ClearPoint Neuro (CLPT) Price to Sales (2012 - 2026)

ClearPoint Neuro has disclosed Price to Sales across 14 years of filings, most recently posting 50.02 for Q2 2026.

• In Q2 2026, Price to Sales rose 35.81% year-over-year to 50.02; the TTM figure through Jun 2026 stood at 12.87 (up 27.4% YoY), while the FY2025 annual figure was 10.87, down 19.69% from the prior year.
• Price to Sales came in at 50.02 for Q2 2026 at ClearPoint Neuro, up from 22.5 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 69.91 in Q3 2025 to a low of 18.92 in Q2 2024.
• Average Price to Sales over 5 years is 39.3, with a median of 38.39 recorded in 2025.
• Year-over-year, Price to Sales tumbled 56.59% in 2023 and soared 122.37% in 2024.
• Over 5 years, Price to Sales stood at 40.24 in 2022, then sank by 38.91% to 24.58 in 2023, then soared by 122.37% to 54.66 in 2024, then dropped by 29.39% to 38.59 in 2025, then gained by 29.6% to 50.02 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 50.02 in Q2 2026, 22.5 in Q1 2026, and 38.59 in Q4 2025.